A low white blood cell count is called neutropenia and occurs when your body does not have enough white blood cells to ...

Blood tests set to norms based on the physiology of white men can lead to misdiagnosis and unnecessary health scares for ...

While infections pose a risk for morbidity and mortality among patients with MDS, more needs to be studied about the topic, ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

Late-onset neutropenia (LON) is emerging as a common adverse effect to rituximab therapy owing to widespread use of this drug in the treatment of B-cell lymphomas and autoimmune diseases.

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...

For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis ...

With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...

Seres Therapeutics' financial moves, potential drug developments, and investment appeal for speculative buyers in the biotech ...

When the neutrophil count is too low, it is known as neutropenia. Typically, a low neutrophil count (neutropenia) results in ...